Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2020 Feb 14;92(12):3073–3080. doi: 10.1002/jmv.25686

Development and evaluation of a panel of multiplex one‐tube nested real time PCR assay for simultaneous detection of 14 respiratory viruses in five reactions

Li Zhao 1, Gui‐xia Li 2, Ji Wang 3, Meng‐chuan Zhao 2, Le Wang 2, Zhi‐shan Feng 4,, Xue‐jun Ma 3,
PMCID: PMC7228275  PMID: 31981228

Abstract

Multiplex real‐time quantitative polymerase chain reaction (mRT‐qPCR) assay is commonly used to detect respiratory viruses, however, the sensitivity is limited for most reports. A panel of locked nucleic acid based multiplex closed one‐tube nested real‐time PCR (mOTNRT‐PCR) assay consisting of five separate internally controlled RT‐qPCR assays was developed for detection of 14 respiratory viruses. The sensitivity and reproducibility of mOTNRT‐PCR panel were evaluated using plasmid standards and the specificity was evaluated using clinical samples. The clinical performance of mOTNRT‐PCR panel was further evaluated with 468 samples collected from patients with an acute respiratory infection and compared with individual real‐time PCR (RT‐qPCR) assay. The analytical sensitivities of mOTNRT‐PCR panel ranged from 2 to 20 copies/reaction, and no cross‐reaction with common respiratory viruses was observed. The coefficients of variation of intra‐assay and inter‐assay were between 0.35% and 8.29%. Totally 35 clinical samples detected by mOTNRT‐PCR assay panel were missed by RT‐qPCR and confirmed true positive by sequencing of nested PCR products. The mOTNRT‐PCR assay panel provides a more sensitive and high‐throughput method for the detection of 14 respiratory viruses.

Keywords: locked nucleic acid (LNA), multiplex one‐tube nested real‐time PCR (mOTNRT‐PCR), respiratory virus

Research Highlights

  • A panel of mOTNRT‐PCR consisted of five separate internally controlled RT‐qPCR assay.

  • Locked nucleic acid was used to develop the mOTNRT‐PCR assay panel.

  • The sensitivity of mOTNRT‐PCR panel ranged from 2‐20copies/reaction using plasmid.

  • mOTNRT‐PCR was more sensitive than reported individual RT‐qPCR assay.

1. INTRODUCTION

Respiratory viral infection causes widespread hospitalization rates and mortality rates in children and especially causes more deaths worldwide in children less than 5 years. 1 , 2 The common respiratory virus are respiratory syncytial virus (RSV), human rhinovirus (HRV), human parainfluenza virus (PIV), influenza A virus (FluA), influenza B virus (FluB), adenovirus (ADV), human coronavirus (HCoV), human metapneumovirus (HMPV), human bocavirus (HBoV), and enterovirus (EV). 3 In recent years, many mono real‐time quantitative PCR (RT‐qPCR), multiplex reverse transcription PCR and multiplex real‐time quantitative PCR (mRT‐qPCR) were widely applied in well‐equipped laboratories for detection of respiratory virus. The mono RT‐qPCR 4 has acceptable sensitivity and specificity for detection of respiratory virus, but only detects one virus per tube. The multiplex reverse transcription PCR 1 enables the detection of virus coinfection but is labor‐intensive and susceptible to cross‐contamination as it requires post PCR analysis. The mRT‐qPCR 5 has the advantages of high throughput detection and labor‐saving, however, the sensitivity is not yet adequate for assessing clinical specimens with a low viral load.

In our previous study, we successfully applied the locked nucleic acid (LNA) technology to develop the OTNRT‐PCR assay to detect RSV 6 and the mOTNRT‐PCR assay to detect RSV, HRV, and HMPV in one tube, 7 however, we only included 3 respiratory viruses. Aiming to detect more respiratory viruses and improve the sensitivity of the mRT‐qPCR, in the present study, we adopted the design of locked nucleic acid‐modified primers and developed a multiplex one‐tube nested real‐time PCR (mOTNRT‐PCR) assay panel with the advantages of higher sensitivity, easier performance, and better cost‐effectiveness.

2. MATERIALS AND METHODS

2.1. Clinical samples

A total of 468 nasopharyngeal aspirates samples were collected from inpatients presenting with acute respiratory symptoms at the Children's Hospital of Hebei Province (China) from June to October, 2017 and from February to June, 2018. Of those 264 (56.41%) were female and 204 (43.59%) were male. Ages ranged from 34 days to 11 years old and 453 (96.79%) were under 5 years old. Briefly, 1.8 mL of nasopharyngeal aspirate was collected in 2 mL of transport medium containing sodium glycerophosphate, sodium thioglycolate, cysteine hydrochloride, CaCl2, methylene blue, and agar and stored at −80°C. The study was conducted with the approval of the Ethics Committee of Children's Hospital of Hebei Province, and written informed consent was obtained from the children's parents.

2.2. Nucleic acid extraction

Total RNA/DNA was extracted from 200 µL of clinical samples using the QIAamp MinElute Virus Spin Kit (Qiagen, Hilden, Germany). The extracts were eluted in 50 µL of DNase‐free and RNase‐free diethylpyrocarbonate(DEPC)‐treated water and stored at −80°C until use.

2.3. Primers and probes design for mOTNRT‐PCR assay panel

The mOTNRT‐PCR assay panel consisted of five separate internally controlled RT‐qPCR assays targeting 14 respiratory viruses. Assay 1, RSV, HRV, and HMPV; assay 2, PIV1, PIV2, and PIV3; assay 3, EV, FluA, and FluB; assay 4, HCoV229E, HCoVOC43 and HCoVNL63; assay 5, ADV, HBoV, and Rnasep. All the sequences of LNA‐outer primer, inner primer, and probe were obtained either from the reported literature 4 , 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 or slightly modified by removing a few bases of reported inner primers. All the outer primers were modified by LNA. BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) was then performed to ensure the specificity of primers and probes. All the primers probes were tested using Oligo7 to minimize duplex formation and hairpin formation. The primers and probes were synthesized from Sangon Biotech (Shanghai, China). The detailed sequences of primer and probe are shown in Table 1.

Table 1.

Primers and probes used in the multiplex closed one‐tube nested real‐time polymerase chain reaction assay panel

Assay Primer/Probe Sequence (5′‐3′) Product size, bp Gene References
1 RSV‐outer‐F a CA+CW+GAA+GA+TG+CWAAT+CATAAATTCA 374 N Kim et al 8 ; Sanghavi et al 9
RSV‐outer‐R a CW+GA+TC+TRT+CT+CCT+GCTGCTA
RSV‐inner‐F CACWGAAGATGCWAATCATAAATTCA 89
RSV‐inner‐R GTATYTTTATRGTGTCTTCYCTTCCTAACC
RSV‐Probe FAM‐TAATAGGTATGTTATATGCKATGTC‐BHQ1
HRV‐outer‐F a HC+AA+GYA+CTTCT+GTYWCCCCSG 397 5′UTR Wisdom et al 10 ; Hammitt et al 11
HRV‐outer‐R a GA+AA+CAC+GGA+CA+CCCAAAGTAGT
HRV‐inner‐F TGGACAGGGTGTGAAGAGC 144
HRV‐inner‐R CAAAGTAGTCGGTCCCATCC
HRV‐Probe CY5‐TCCTCCGGCCCCTGAATG‐BHQ3
HMPV‐outer‐F a CATATAAG+CA+T+G+C+TA+TATTAAAA+GAGTCTC 475 N Maertzdorf et al 4 ; Dare et al 12
HMPV‐outer‐R a GT+GAATATTAA+G+G+CA+C+CTACACATAATAARA
HMPV‐inner‐F CATATAAGCATGCTATATTAAAAGAGTCTC 163
HMPV‐inner‐R CCTATTTCTGCAGCATATTTGTAATCAG
HMPV‐Probe VIC‐TGYAATGATGAGGGTGTCACTGCGGTTG‐BHQ1
2 PIV1‐outer‐F a A+GGA+TGT+G+CA+GATATAGGGAA 195 HN Perrott et al 13
PIV1‐outer‐R a GT+CT+CA+TT+CA+CAGTGGGCAA
PIV1‐inner‐F TTTAAACCCGGTAATTTCTCATACCT 81
PIV1‐inner‐R CCCCTTGTTCCTGCAGCTATT
PIV1‐Probe FAM‐TGACATCAACGACAACAGGAAATCATGTTCTG‐BHQ1
PIV2‐outer‐F a AA+C AA+T+CT+G+CTG CAGCAT TT 158 HN Sanghavi et al 9 ; Bellau‐Pujol et al 14
PIV2‐outer‐R a C+GT+GG+CA+TA+AT+CTTCTTTTT
PIV2‐inner‐F CCATTTACCTAAGTGATGGAA 116
PIV2‐inner‐R CGTGGCATAATCTTCTTTTT
PIV2‐Probe CY5‐AATCGCAAAAGCTGTTCAGTCAC‐BHQ3
PIV3‐outer‐F a T+TA+CARA+TA+GG+GATAATAACTGT 151 HN Sanghavi et al 9 ; Bellau‐Pujol et al 14
PIV3‐outer‐R a CTTT+GG+GA+GTT+GAACACAGTT
PIV3‐inner‐F TTACARATAGGGATAATAACTGT 115
PIV3‐inner‐R TTAGGAGTGCTAGAGAACAT
PIV3‐Probe VIC‐AAACTCAGACTTGGTACCTGACTTAAAT‐BHQ1
3 EV‐outer‐F a HC+AA+GYA+CTTCT+GTYWCCCCSG 402 5′UTR Wisdom et al 10 ; Brittain‐Long et al 15 modified
EV‐outer‐R a GA+AA+CAC+GGA+CA+CCCAAAGTAGT
EV‐inner‐F GTGYGAAGAGTCTATTGAGCTA 141
EV‐inner‐R ACACCCAAAGTAGTCGGTT
EV‐Probe FAM‐CGGCCCCTGAATGCGGCTAATC‐BHQ1
FluA‐outer‐F a TCA+AAGC+CGAGATCGCGCAG 189 M This study
FluA‐outer‐R a G+CATT+TTG+GA+CAAAGCGTCTAC Lee et al 16 modified
FluA‐inner‐F GAATGGCTAAAGACAAGACCAAT 118
FluA‐inner‐R GCATTTTGGACAAAGCGTCTAC
FluA‐Probe CY5‐AGTCCTCGCTCACTGGGCACGGTG‐BHQ3
FluB‐outer‐F a TG+CCT+CCAC+AAAAATACGG 218 HA Perrott et al 13
FluB‐outer‐R a C+C+TG+CAAT+CATTCCTTCCCA
FluB‐inner‐F AAATACGGTGGATTAAATAAAAGCAA 170
FluB‐inner‐R CCA GCA ATA GCT CCG AAG AAA
FluB‐Probe VIC‐CACCCATATTGGGCAATTTCCTATGGC‐BHQ1
4 HCoV229E‐outer‐F a CA+GT+CAAAT+GGGCTGATGCA 638 N Hammitt et al 11 ; Li et al 17 modified
HCoV229E‐outer‐R a A+CGA+GAA+GG+CTTAGGAGTAC
HCoV229E‐inner‐F CAGTCAAATGGGCTGATGCA 76
HCoV229E‐inner‐R AAAGGGCTATAAAGAGAATAAGGTATTCT
HCoV229E‐Probe FAM‐CCCTGACGACCACGTTGTGGTTCA‐BHQ1
HCoVOC43‐outer‐F a ATT+GCA+CCA+GGAGTCCCA 316 N Hammitt et al 11 ; Li et al 17 modified
HCoVOC43‐outer‐R a TT+CC+T+GA+GC+CTT+CAATATAGTAAC
HCoVOC43‐inner‐F ATGAGGCTATTCCGACTAGG 72
HCoVOC43‐inner‐R TTCCTGAGCCTTCAATATAGTAAC
HCoVOC43‐Probe CY5‐TCCGCCTGGCACGGTACTCCCT‐BHQ3
HCoVNL63‐outer‐F a A+GATGA+GCA+GATT+GGTTATTGG 211 N Bastein et al 18 ; Esposito et al 19 modified
HCoVNL63‐outer‐R a ATTACGTTT+GC+GATTA+C+CAAGACT
HCoVNL63‐inner‐F GACCTTAAATTCAGACAACGTTCT 96
HCoVNL63‐inner‐R ATTACGTTTGCGATTACCAAGACT
HCoVNL63‐Probe VIC‐TAACAGTTTTAGCACCTTCCTTAGCAACCCAAACA‐BHQ1
5 ADV‐outer‐F a TACATGCA+CATCKCSGGVCAGGA 113 Hexo Sanghavi et al 9 ; Lam et al 20 modified
ADV‐outer‐R a GT+GG+GGTTYCT+GAACTTGT
ADV‐inner‐F GCY TCG GAG TAC CTG AG 89
ADV‐inner‐R GTGGGGTTYCTGAACTTGT
ADV‐Probe FAM‐CTGGTGCAGTTCGCCCGTGCCA‐BHQ1
HBoV‐outer‐F a GA+C+TAA+GCAA+GAG+GAATGCTA 214 NS1 Chieochansin et al 21 ; Jansen et al 22 modified
HBoV‐outer‐R a TCT+GC+GAT+CT+CT+ATATT+GAAGG
HBoV‐inner‐F AAATCTCTTCTGGCTACACG 136
HBoV‐inner‐R TCTGCGATCTCTATATTGAAGG
HBoV‐Probe CY5‐ATGTTGCCGCCAGTAACTCCACC‐BHQ3
Rnasep‐F AGATTTGGACCTGCGAGCG 65 Rnasep Zhang et al 5
Rnasep‐R GAGCGGCTGTCTCCACAAGT
Rnasep‐Probe VIC‐TTCTGACCTGAAGGCTCTGCGCG‐BHQ1

Note: modified, the internal primers from the literature were modified by removing a few bases.

Abbreviations: ADV, adenovirus; BHQ, Blackblack hole quencher; CY5, Cyanine‐5; EV, enterovirus; FAM, 6‐carboxyfluorescein; FluA, influenza A virus; FluB, influenza B virus; HRV, human rhinovirus; HBoV, human bocavirus; HCoV, human coronavirus; HMPV, human metapneumovirus; LNA, locked nucleic acid; PIV, human parainfluenza virus; RSV, respiratory syncytial virus; VIC, 2′‐chloro‐7′‐phenyl‐1,4‐dichloro‐6‐carboxyfluorescein;2′‐chloro‐7′‐phenyl‐1,4‐dichloro.

a

'+' denotes a nucleotide with LNA modification.

2.4. Preparation of plasmid standards

PCR products of outer primers of mOTNRT‐PCR assay panel targeting 14 respiratory viruses were cloned respectively by TsingKe Biotech Corp (Beijing, China) and confirmed by sequencing. The recombinant plasmids were quantified using a Qubit dsDNA HS Assay Kits (Life technologies Invitrogen). For mOTNRT‐PCR assay panel, each standard plasmid was adjusted to a concentration of 107 copies/µL and equally mixed in each assay. The mixed plasmids were used to prepare 10‐fold serial dilutions for sensitivity analysis.

2.5. mOTNRT‐PCR assay panel

Each assay of mOTNRT‐PCR panel was carried out in a 10 µL reaction volume using a One‐Step RT‐PCR kit (Qiagen, Hilden, Germany), containing 2 µL of extracted sample, 2 µL of the 5× buffer, 0.4 µL of the dNTP mix, 0.8 µL of the enzyme mix, 0.05 µL of RRI (Takara, Dalian, China). One microliter of 10× Primers and probes mix, and 3.75 µL of RNase‐free water. PCR amplification was performed on the CFX96 Real‐Time PCR System (Bio‐Rad) and the conditions were: 50°C for 30 minutes, a 15 minutes denaturation step at 95°C, and 10 cycles at 94°C for 30 seconds, 64°C for 40 seconds and 72°C for 40 seconds, followed by 40 cycles at 94°C for 30 seconds, 54°C for 30 seconds, and 72°C for 30 seconds, with fluorescent readings taken at the annealing phase of the last 40 cycles. Cycle threshold (C t) values were calculated using the software at the automatic threshold setting. Positive and negative controls were included in each run. The results were defined as positive if the C t value was not higher than 35 for all the reactions.

2.6. Analytical sensitivity, reproducibility, and specificity of the mOTNRT‐PCR assay panel

Ten‐fold dilutions of mixed recombinant plasmids ranging from 107 to 100 copies/µL were used to analyze the sensitivity of the mOTNRT‐PCR assay panel in five reactions. In a 10 µL reaction system, the reaction mixture was prepared to contain 5 µL of 2× Qiagen Multiplex PCR Master Mix (Qiagen), 2 µL of mixed plasmid, 1 µL of 10× Primers and probes mix, and 2 µL of RNase‐free water. PCR amplification was performed on the CFX96 Real‐Time PCR System (Bio‐Rad) and the conditions were: a 15 minutes denaturation step at 95°C, and 10 cycles at 94°C for 30 seconds, 64°C for 40 seconds and 72°C for 40 seconds, followed by 40 cycles at 94°C for 30 seconds, 54°C for 30 seconds and 72°C for 30 seconds, with fluorescent readings taken at the annealing phase of the last 40 cycles. The reproducibility of the mOTNRT‐PCR was evaluated using three concentrations of mixed recombinant plasmids (106, 104, and 102 copies/µL). Intra‐assay reproducibility and inter‐assay reproducibility of mOTNRT‐PCR were tested using three plasmids in three replicates and in three different days within a week.The specificity was retrospectively evaluated by using archived common respiratory viruses‐positive samples previously tested by respiratory pathogen 13 detection kit (13 × kit) in our lab. 23

2.7. Comparison of clinical performance between the mOTNRT‐PCR assay panel and the RT‐qPCR assay

A total of 468 clinical samples were detected by mOTNRT‐PCR. For comparison, the previously published RT‐qPCR assays 9 , 11 , 12 , 13 , 15 , 16 , 19 , 22 were also performed in parallel. Sequencing of traditional two‐step nested PCR 14 , 20 , 24 products were performed to resolve discrepant results among the two assays.

2.8. Statistical analysis

IBM SPSS Statistics, version 21 (IBM Corporation, NY) was used to perform statistical analysis. The results were analyzed using χ 2 tests, and value of P < 0.05 was considered statistically significant.

3. RESULTS

3.1. Sensitivity, reproducibility, and specificity of the mOTNRT‐PCR assay panel

The sensitivity was analyzed using 10‐fold dilutions of mixed recombinant plasmids ranging from 107 to 100 copies/µL, yielding 20 copies/reaction for PIV1, PIV2, and PIV3, and 2 copies/reaction for other 11 viruses type/subtype. The coefficient of variation (CV) for intra‐assay and inter‐assay ranged from 0.35% to 3.66% and 0.83% to 8.29% (Table 2). A total of 407 archived positive clinical samples retrospectively detected by 13 kit 23 were used to assess the specificity of the mOTNRT‐PCR. No cross‐reaction was obtained (data not shown), indicating high specificity for the mOTNRT‐PCR panel.

Table 2.

The intra‐assay and inter‐assay reproducibility of the multiplex closed one‐tube nested real‐time polymerase chain reaction assay panel

Intra‐ssay CV (%) Inter‐ssay CV (%)
Virus 2 × 106 (copies/reaction) 2 × 104 (copies/reaction) 2 × 102 (copies/reaction) 2 × 106 (copies/reaction) 2 × 104 (copies/reaction) 2 × 102 (copies/reaction)
RSV 3.66 0.64 1.57 3.67 3.19 0.83
HRV 0.74 1.36 0.51 1.87 1.91 2.13
HMPV 3.39 1.33 2.01 3.45 1.91 1.20
EV 0.35 0.62 2.18 2.93 3.75 2.05
FluA 1.12 0.62 1.35 8.29 3.57 2.58
FluB 2.09 1.87 1.59 5.48 2.96 2.10
PIV1 1.61 1.03 1.12 4.26 2.09 1.05
PIV2 1.02 1.23 1.05 1.90 2.04 1.93
PIV3 0.79 1.07 0.99 1.46 1.55 1.55
HCoV229E 2.49 1.13 0.91 2.06 1.97 1.12
HCoVOC43 1.50 1.75 0.97 1.50 2.54 1.99
HCoVNL63 3.23 1.07 1.50 2.05 1.81 1.21
ADV 2.66 1.75 0.58 3.92 2.05 2.61
HBoV 3.25 1.39 0.89 3.60 4.76 2.36

Abbreviations: ADV, adenovirus; CV, coefficient of variations; EV, enterovirus; FluA, influenza A virus; FluB, influenza B virus; HCoV, human coronavirus; HMPV, human metapneumovirus; HRV, human rhinovirus; HCoV, human coronavirus; PIV, human parainfluenza virus; RSV, respiratory syncytial virus.

3.2. Comparison of clinical performance between the mOTNRT‐PCR assay panel and the RT‐qPCR assay

All of the 468 clinical samples were tested by the mOTNRT‐PCR assay panel and the RT‐qPCR assay in parallel. Totally, 427 of 468 (91.24%) specimens were positive by mOTNRT‐PCR, including 262 (55.98%), 135 (28.85%), 29 (6.20%), and 1(0.21%) samples were positive for a single virus, 2 viruses, 3 viruses, and 4 viruses, respectively. As shown in Table 3 and Figure 1, HRV, RSV, and PIV3 were the most frequently viruses detected by mOTNRT‐PCR assay with 179 (38.25%), 97 (20.73%), and 42 (8.97%), respectively. RT‐qPCR assay detected HRV 174 (37.18%), RSV 94 (20.09%), and PIV3 38 (8.12%), respectively. HCoVNL63 was not detected by either assay. A total of 35 clinical samples were positive by the mOTNTR‐PCR assay but negative by the RT‐qPCR assay using the cutoff of the RT‐qPCR assay with Ct > 40. Sequencing of traditional two‐step nested PCR 14 , 20 , 24 products confirmed that 35 samples were true positives. The comparison of percentages of detection of specimens with C t ≤ 40 between the mOTNRT‐PCR and mono RT‐qPCR for a total of 468 clinical samples is displayed in Figure 1. A total of 69 clinical samples detected by mOTNRT‐PCR assay were missed by RT‐qPCR using the positivity cutoff (Ct = 35) of the RT‐qPCR assay. Among them, 34 samples had a CT range of 35 to 40 detected by RT‐qPCR assay. The sensitivities of detection of the different viruses were 100%, and the specificities were more than 98% between the mOTNTR‐PCR assay and the RT‐qPCR assay. Concordance between the two assays for all viruses was more than 98%, and the kappa correlation ranged from 0.66 to 0.98.

Table 3.

Clinical performance of the multiplex closed one‐tube nested real‐time polymerase chain reaction panel compared with the real‐time quantitative polymerase chain reaction

Virus No. of samples C t value Clinical performance of the mOTNRT‐PCR compared with the RT‐qPCR
mOTNRT‐PCR RT‐qPCR mOTNRT‐PCR vs RT‐qPCR Sensitivity, % Specificity, % Accordance rate, % Kappa value
RSV 97/468 94/468 12.37‐35.00 vs 18.03‐39.56 100 99.20 99.36 0.98
HRV 179/468 174/468 7.58‐33.43 vs 21.01‐39.66 100 98.30 98.93 0.98
HMPV 36/468 34/468 10.79‐34.85 vs 18.62‐38.84 100 99.54 99.57 0.97
EV 18/468 15/468 13.06‐32.13 vs 19.20‐37.65 100 99.33 99.36 0.91
FluA 34/468 32/468 10.01‐29.53 vs 19.65‐37.39 100 99.54 99.57 0.97
FluB 15/468 13/468 13.14‐34.15 vs 21.21‐39.18 100 99.56 99.57 0.93
PIV1 23/468 21/468 8.38‐34.99 vs 18.31‐39.69 100 99.55 99.57 0.95
PIV2 6/468 3/468 20.06‐31.63 vs 36.14‐39.89 100 99.35 99.35 0.66
PIV3 42/468 38/468 12.77‐31.03 vs 24.00 −39.61 100 99.07 99.14 0.95
HCoV229E 5/468 3/468 19.98‐25.69 vs 28.65‐34.98 100 99.57 99.57 0.75
HCoVOC43 10/468 9/468 10.37‐28.94 vs 19.04‐36.62 100 99.78 99.79 0.95
HCoVNL63 0/468 0/468 NA NA 100 100 NA
ADV 35/468 31/468 13.66‐34.52 vs 22.90‐38.63 100 99.08 99.15 0.93
HBoV 18/468 16/468 9.40‐35.00 vs 16.02‐39.01 100 99.56 99.57 0.94

Abbreviations: ADV, adenovirus; CV, coefficient of variations; FluA, influenza A virus; FluB, influenza B virus; HBoV, human bocavirus; HMPV, human metapneumovirus; HRV, human rhinovirus; HCoV, human coronavirus; mOTNRT‐PCR, multiplex closed one‐tube nested real‐time polymerase chain reaction; PIV, human parainfluenza virus; RSV, respiratory syncytial virus; RT‐qPCR, real‐time quantitative polymerase chain reaction.

Figure 1.

Figure 1

The percentages of detection of specimens with C t ≤ 40 analyzed by mOTNRT‐PCR panel (M) and mono RT‐qPCR (S) for a total of 468 clinical samples. A total of 34 samples had a C t range of 35 to 40 detected by RT‐qPCR assay. mOTNRT‐PCR, multiplex closed one‐tube nested real‐time polymerase chain reaction; RT‐qPCR, real‐time quantitative polymerase chain reaction

4. DISCUSSION

LNA has been reported to modify primers and probes in many studies, thus increasing the maximum annealing temperature of primers/probes and improving amplification sensitivity and specificity. 25 , 26 In the present study, LNA‐modified outer primers (without changing the sequences) were used to develop an mOTNRT‐PCR assay panel for simultaneous detection of 14 respiratory viruses in five reactions. The purpose of this design was to maximize the difference in the annealing temperatures (64°C vs 54°C) between the outer primer modified by LNA and inner primer sets, allowing one‐step nested amplification successfully to be carried out via temperature switch PCR (TSP). 27 , 28 To our best knowledge, this is the first report on the simultaneous detection of 14 respiratory viruses in five closed one‐tube reactions using LNA.

For the mOTNRT‐PCR assay panel, the working concentration of LNA‐modified outer primers, inner primers, and probes in each reaction was carefully optimized, enabling minimize the competition between the outer primers and inner primers, as well as primers and probes of targeted viruses in each reaction. The reaction parameters and the running conditions of the mOTNRT‐PCR assay were also optimized, allowing the five reactions to perform simultaneously. This study demonstrated that mOTNRT‐PCR assay panel revealed high sensitivity range from 2 to 20 copies/reaction of 14 respiratory viruses using 10‐fold dilutions of mixed recombinant plasmids, high specificity, and reliable reproducibility (Table 3).

The mOTNRT‐PCR assay panel was further evaluated and compared with the RT‐qPCR assay using 468 clinical samples. As shown in Table 3 and Figure 1, HRV, RSV, and PIV3 were the most commonly found respiratory viruses by the two assays which is consistent with the previous report. 17 The reported RT‐qPCR thresholds typically ranged from 35 to 40. A total of 69 clinical samples detected by the mOTNRT‐PCR assay were missed by RT‐qPCR using the positivity cutoff of the RT‐qPCR assay set at a C t of 35. When a C t cutoff of 40 for RT‐qPCR was used, 35 samples were deemed to be positive by mOTNRT‐PCR assay but negative by RT‐qPCR (Table 3 and Figure 1). Moreover, the range of C t values of the mOTNRT‐PCR assay (7.58‐35.00) was smaller than the RT‐qPCR (16.02‐39.89) in those positive samples using both assays (Table 3), suggesting that the mOTNRT‐PCR assay is more sensitive than the reported RT‐qPCR assay in detecting clinical specimens. Besides, the mOTNRT‐PCR can detect 14 common respiratory viruses in five reactions in 2.7 hours and cost $7.5 (excluding nucleic acid extraction) for one sample. Compared with the mono RT‐qPCR assay for detecting one virus per tube, the mOTNRT‐PCR has the advantages of being highly sensitive, easy to operate, rapid, and cost‐effective. In addition, the human RNasep gene as an internal control can validate the RNA extraction procedure and prevent errors in the process of sampling and RT‐PCR.

As to the mixed infections, 165 of 468 (35.26%) specimens were detected by the mOTNRT‐PCR, including 135 of 468 (28.85%), 29 of 468 (6.20%) and 1 of 468 (0.21%) samples involved in 2 viruses, 3 viruses, and 4 viruses, respectively. Virus coinfections were more frequently detected in children less than 5 years old (32.05%, 150/468) compared with the older children (3.21%; 15/468; P < 0.05). For children less than 5 years, RSV and HRV (7.05%, 33/468) were the most commonly found in co‐infections, which is similar to the previous report. 29

The mOTNRT‐PCR assay panel has limitations. First, it requires five parallel assays with only moderate throughput in each assay. Second, we only evaluate the clinical specimens from children and the clinical data is incomplete. Future research will attempt to develop a mOTNRT‐PCR assay to detect as many viruses as possible in one assay, evaluate a large number of samples from different populations and integrate clinical information for more comprehensive analysis.

In summary, the mOTNRT‐PCR assay developed in this study using LNA is a sensitive, labor‐saving, and cost‐effectiveness method for detecting 14 respiratory viruses in five reactions. It may have great potential for routine surveillance of respiratory virus infection in China.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

ETHICS STATEMENT

All aspects of the study were performed in accordance with national ethics regulations and approved by the Institutional Review Boards of National Institute for Viral Disease Control and Prevention, Center for Disease Control and Prevention of China.

ACKNOWLEDGMENTS

This work was supported by grants from China Mega‐Projects for Infectious Disease (2018ZX10711001, 2017ZX10104001, and 2018ZX10713‐002) and Hebei Key Project Plan for Medical Science Research (20180616).

Zhao L, Li G‐x, Wang J, et al. Development and evaluation of a panel of multiplex one‐tube nested real time PCR assay for simultaneous detection of 14 respiratory viruses in five reactions. J Med Virol. 2020;92:3073–3080. 10.1002/jmv.25686

Contributor Information

Zhi‐shan Feng, Email: 15131129999@139.com.

Xue‐jun Ma, Email: maxj@ivdc.chinacdc.cn.

REFERENCES

  • 1. Li J, Qi S, Zhang C, et al. A two‐tube multiplex reverse transcription PCR assay for simultaneous detection of sixteen human respiratory virus types/subtypes. BioMed Res Int. 2013;2013:327620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Williams BG, Gouws E, Boschi‐Pinto C, Bryce J, Dye C. Estimates of worldwide distribution of child deaths from acute respiratory infections. Lancet Infect Dis. 2002;2(1):25‐32. [DOI] [PubMed] [Google Scholar]
  • 3. Radko S, Ian Stuart J, Zahariadis G. Evaluation of three commercial multiplex assays for the detection of respiratory viral infections. J Virol Methods. 2017;248:39‐43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Maertzdorf J, Wang CK, Brown JB, et al. Real‐time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J Clin Microbiol. 2004;42(3):981‐986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Zhang D, Mao H, Lou X, et al. Clinical evaluation of a panel of multiplex quantitative real‐time reverse transcription polymerase chain reaction assays for the detection of 16 respiratory viruses associated with community‐aacquired pneumonia. Arch Virol. 2018;163(10):2855‐2860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Zhao L, Wang J, Li G, et al. A highly sensitive 1‐tube nested real time RT‐PCR assay using LNA‐modified primers for detection of respiratory syncytial virus. Diagn Microbiol Infect Dis. 2019;93(2):101‐106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Feng Z, Zhao L, Wang J, et al. A multiplex one‐tube nested real time RT‐PCR assay for simultaneous detection of respiratory syncytial virus, human rhinovirus and human metapneumovirus. Virol J. 2018;30(1):167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Kim H, Kang N, An K, Kim D, Koo J, Kim MS. MRPrimerV: a database of PCR primers for RNA virus detection. Nucleic Acids Res. 2017;45(D1):D475‐D481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Sanghavi SK, Bullotta A, Husain S, Rinaldo CR. Clinical evaluation of multiplex real‐time PCR panels for rapid detection of respiratory viral infections. J Med Virol. 2012;84(1):162‐169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Wisdom A, Leitch ECM, Gaunt E, Harvala H, Simmonds P. Screening respiratory samples for detection of human rhinoviruses (HRVs) and enteroviruses: comprehensive VP4‐VP2 typing reveals high incidence and genetic diversity of HRV species C. J Clin Microbiol. 2009;47(12):3958‐3967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Hammitt LL, Kazungu S, Welch S, et al. Added value of an oropharyngeal swab in detection of viruses in children hospitalized with lower respiratory tract infection. J Clin Microbiol. 2011;49(6):2318‐2320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Dare R, Sanghavi S, Bullotta A, et al. Diagnosis of human metapneumovirus infection in immunosuppressed lung transplant recipients and children evaluated for pertussis. J Clin Microbiol. 2007;45(2):548‐552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Perrott P, Smith G, Ristovski Z, Harding R, Hargreaves M. A nested real‐time PCR assay has an increased sensitivity suitable for detection of viruses in aerosol studies. J Appl Microbiol. 2009;106(5):1438‐1447. [DOI] [PubMed] [Google Scholar]
  • 14. Bellau‐Pujol S, Vabret A, Legrand L, et al. Development of three multiplex RT‐PCR assays for the detection of 12 respiratory RNA viruses. J Virol Methods. 2005;126(1‐2):53‐63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Brittain‐Long R, Nord S, Olofsson S, Westin J, Anderson LM, Lindh M. Multiplex real‐time PCR for detection of respiratory tract infections. J Clin Virol. 2008;41(1):53‐56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Lee HK, Loh TP, Lee CK, Tang JWT, Chiu L, Koay ESC. A universal influenza A and B duplex real‐time RT‐PCR assay. J Med Virol. 2012;84(10):1646‐1651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Li J, Mao NY, Zhang C, et al. The development of a GeXP‐based multiplex reverse transcription‐PCR assay for simultaneousdetection of sixteen human respiratory virus types/subtypes. BMC Infect Dis. 2012;12:189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Bastien N, Robinson JL, Tse A, Lee BE, Hart L, Li Y. Human coronavirus NL‐63 infections in children: a 1‐year study. J Clin Microbiol. 2005;43(9):4567‐4573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Esposito S, Bosis S, Niesters HGM, et al. Impact of human coronavirus infections in otherwise healthy children who attended an emergency department. J Med Virol. 2006;78(12):1609‐1615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Lam WY, Yeung ACM, Tang JW, et al. Rapid multiplex nested PCR for detection of respiratory viruses. J Clin Microbiol. 2007;45(11):3631‐3640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Chieochansin T, Chutinimitkul S, Payungporn S, et al. Complete coding sequences and phylogenetic analysis of human bocavirus (HBoV). Virus Res. 2007;129(1):54‐57. [DOI] [PubMed] [Google Scholar]
  • 22. Jansen RR, Schinkel J, Koekkoek S, et al. Development and evaluation of a four‐tube real time multiplex PCR assay covering fourteen respiratory viruses, and comparison to its corresponding single target counterparts. J Clin Virol. 2011;51(3):179‐185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Zhao M, Li G, Zhang D, et al. Clinical evaluation of a new single‐tube multiplex reverse transcription PCR assay for simultaneous detection of 11 respiratory viruses, Mycoplasma pneumoniae and Chlamydia in hospitalized children with acute respiratory infections. Diagn Micr Infec Dis. 2017;88(2):115‐119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Manning A, Russell V, Eastick K, et al. Epidemiological profil and clinical associations of human bocavirus and other human parvoviruses. J Infect Dis. 2006;194(9):1283‐1290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Osterback R, Tevaluoto T, Ylinen T, et al. Simultaneous detection and differentiation of human rhino and enteroviruses in clinical specmens by real‐time PCR with locked nucleic acid probes. J Clin Microbiol. 2013;51(12):3960‐3967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Ballantyne KN, van Oorschot RAH, Mitchell RJ. Locked nucleic acids in PCR primers increase sensitivity and performance. Genomics. 2008;91(3):301‐305. [DOI] [PubMed] [Google Scholar]
  • 27. Niu P, Qi S, Yu B, et al. Development of a highly sensitive real‐time nested RT‐PCR assay in a single closed tube for detection of enterovirus 71 in hand, foot and mouth disease. Arch Virol. 2016;161(11):3003‐3010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Shen X, Qiu F, Zhao H, et al. A novel and highly sensitive real‐time nested RT‐PCR assay in a single closed tube for detection of enterovirus. Diagn Microbiol Infect Dis. 2018;90(3):181‐185. [DOI] [PubMed] [Google Scholar]
  • 29. Jiang W, Wu M, Zhou J, et al. Etiologic spectrum and occurrence of coinfections in children hospitalized with community‐acquired pneumonia. BMC Infect Dis. 2017;17(1):787. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Medical Virology are provided here courtesy of Wiley

RESOURCES